Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

NCT02946450 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2016-10-27

No results posted yet for this study

Summary

The purpose of this study is to assess safety of Omnipure inj. (lohexol) contrast media in CT scanning patients

Conditions

  • CT Scanning Patients

Interventions

DRUG

Other: Not applicable-observational study

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02946450 on ClinicalTrials.gov